IBEC and the Blood and Tissue Bank of Catalonia (BST) held a day to explore new collaborations in bioengineering and translational medicine. The meeting, held yesterday at IBEC, highlighted innovative projects, presented a joint PhD programme and strengthened the link between biomedical research and clinical applications.
The Institute for Bioengineering of Catalonia (IBEC) has joined organisations from nine European countries in the Heidelberg Agreement to promote environmental sustainability in the funding of scientific research. The agreement discusses the adoption of practices that ensure environmentally sustainable research and how to move towards this model.
IBEC’s 17th Annual Symposium focused on ‘Bioengineering for Emergent and Advanced Therapies’, one of IBEC’s key application areas. Around 300 people attended the event, including local and international researchers. It was a multidisciplinary environment in which experts from other centres and the IBEC community itself had the opportunity to present their projects and share knowledge.
IBEC is one of the partners in the ambitious European project UNLOOC, a public-private collaboration involving 51 organisations from 10 countries with a budget of €68 million. The consortium aims to develop Organ-on-Chips technologies to reduce the use of animals in drug development and testing, and to improve the accuracy and personalisation of medical treatments.
IBEC principal investigator Zaida Álvarez has received funding from the US National Institutes of Health (NIH) to develop stem cell-based models of the spinal cord. The project, coordinated by Northwestern University with the participation of IBEC and IDIBELL, will make it possible to study neurodegenerative diseases and develop new treatments for spinal cord injuries and other neurodegenerative pathologies.
The second IBEC-WCH Precision Medicine Conference took place last week in Chengdu, China. This is a partnership between the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital (WCH) of Sichuan University, which aims to strengthen scientific collaboration between the two countries.
IBEC researcher Samuel Sánchez has received a Leonardo Grant from the BBVA Foundation. The funding will help him take his research a step further and use organic and biocompatible materials to develop his nanorobots, which will be used as drug carriers to treat bladder cancer.
IBEC Principal Investigator Irene Marco Rius has been selected for the European Research Council (ERC) Starting Grant call to carry out her project ‘LIFETIME’. The project focuses on the study of individual cancer metabolism, which is crucial for less invasive early diagnosis and personalised treatments.
The Institute for Bioengineering of Catalonia (IBEC), a CERCA center, is pleased to announce that Dr. Núria Montserrat, a principal investigator at our institute, has been selected to lead the … Read more
IBEC will coordinate SPM4.0 and participate as a partner in ENTRY-DM, two of the projects selected in the 2023 call for PhD networks within the Marie Skłodowska-Curie Actions (MSCA). Thanks to these two projects, IBEC will add three new PhD students to its staff.